• To complete all validations for new MRL applications within 14 days (by 1st quarter 1998); • to complete the processing of all applications for new MRLs within the legal time frame (throughout 1998); • to continue the assessment for the remaining old substances including homeopathics and herbal remedies leading to 100 opinions being recommended by CVMP (throughout 1998); • to prepare a paper expanding the risk assessment concept for establishment of MRLs (by 3rd quarter 1998); • to redraft Notice to Applicants in Volume VI of the Rules Governing Medicinal Products in the European Community once the amendment of Council Regulation (EEC) No 2377/90 has been adopted (by 3rd quarter 1998); • to ensure consistency of all status and MRL summary reports is maintained fully according to quality control standards established previously (by 4th quarter 1998); and • to finalise revision of guidelines on injection site residues once issues are resolved at Codex Alimentarius (by 4th quarter 1998).